Brexpiprazole for manic episodes in bipolarity type I
This study is completed in the United States, in Bulgaria, in Poland, .... It is testing brexpiprazole for manic episodes in bipolarity type I.
Bipolarity, Manic EpisodeDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Brexpiprazole Versus Placebo may be useful for adults experiencing bipolarity.
What would participation involve?
Participants may receive Brexpiprazole Versus Placebo, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Bulgaria, in Poland, and in Serbia.
Who is it mainly for?
This study appears to be mainly for adults with bipolarity.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: September 14, 2017
Recruitment status
Completed
Enrollment listed in the registry
322
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Bulgaria, Poland, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT03259555
Official title
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Bulgaria · 9 sites
Mental Health Center Prof. Dr. Ivan Temkov - Burgas EOOD
Burgas
Site status: Not listed — confirm with the team
State Psychiatry Hospital - Kardzhali
Kardzhali
Site status: Not listed — confirm with the team
State Psychiatry Hospital Sv. Ivan Rilski
Novi Iskar
Site status: Not listed — confirm with the team
University Multiprofile Hospital for Active Treatment Sveti Georgi EAD
Plovdiv
Site status: Not listed — confirm with the team
Mental Health Center - Ruse EOOD
Rousse
Site status: Not listed — confirm with the team
University Multiprofile Hospital for Active Treatment Alexandrovska EAD
Sofia
Site status: Not listed — confirm with the team
Multiprofile Hospital for Active Treatment - Targovishte AD
Targovishte
Site status: Not listed — confirm with the team
Mental Health Center - Veliko Tarnovo EOOD
Veliko Tarnovo
Site status: Not listed — confirm with the team
Mental Health Center - Vratsa EOOD
Vratsa
Site status: Not listed — confirm with the team
Poland · 4 sites
Samodzielny Publiczny Psychiatryczny Zaklad Opieki Zdrowotnej im. Dr. Stanislawa Deresza w Choroszczy
Choroszcz
Site status: Not listed — confirm with the team
Uniwersyteckie Centrum Kliniczne w Gdansku Klinika Psychiatrii Doroslych
Gdansk
Site status: Not listed — confirm with the team
NZOZ Centrum Medyczne HCP Sp. z o. o.
Poznan
Site status: Not listed — confirm with the team
NZOZ Prywatna Klinika Psychiatryczna Inventiva
Tuszyn
Site status: Not listed — confirm with the team
Serbia · 6 sites
Clinic for Psychiatric Disorders Dr Laza Lazarevic
Belgrade
Site status: Not listed — confirm with the team
Clinical Center of Serbia
Belgrade
Site status: Not listed — confirm with the team
Clinical Hospital Center Dr Dragisa Misovic-Dedinje
Belgrade
Site status: Not listed — confirm with the team
Special Hospital for Psychiatric Diseases Kovin
Kovin
Site status: Not listed — confirm with the team
Clinical Center Kragujevac
Kragujevac
Site status: Not listed — confirm with the team
Clinical Center of Vojvodina
Novi Sad
Site status: Not listed — confirm with the team
United States · 29 sites
Woodland International Research Group
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Woodland Research Northwest, LLC
Rogers, Arkansas
Site status: Not listed — confirm with the team
ProScience Research Group
Culver City, California
Site status: Not listed — confirm with the team
Collaborative Neuroscience Network, LLC
Garden Grove, California
Site status: Not listed — confirm with the team
Behavioral Research Specialists, LLC
Glendale, California
Site status: Not listed — confirm with the team
Pacific Research Partners, LLC
Oakland, California
Site status: Not listed — confirm with the team
NRC Research Institute
Orange, California
Site status: Not listed — confirm with the team
Asclepes Research Centers
Panorama City, California
Site status: Not listed — confirm with the team
Ci Trials
Riverside, California
Site status: Not listed — confirm with the team
Sharp Vista Hospital
San Diego, California
Site status: Not listed — confirm with the team
Galiz Research
Hialeah, Florida
Site status: Not listed — confirm with the team
Advanced Research Institute of Miami
Homestead, Florida
Site status: Not listed — confirm with the team
Florida Behavioral Medicine
Largo, Florida
Site status: Not listed — confirm with the team
Optimus U Corporation
Miami, Florida
Site status: Not listed — confirm with the team
Behavioral Clinical Research, Inc.
North Miami, Florida
Site status: Not listed — confirm with the team
Segal Trials
North Miami, Florida
Site status: Not listed — confirm with the team
Radiant Research Inc.
Atlanta, Georgia
Site status: Not listed — confirm with the team
Alexian Brothers Center for Psychiatric Research
Hoffman Estates, Illinois
Site status: Not listed — confirm with the team
CBH Health
Gaithersburg, Maryland
Site status: Not listed — confirm with the team
Advanced Clinical Research Center, LLC
St Louis, Missouri
Site status: Not listed — confirm with the team
Richard H Weisler, MD, PA, and Associates
Raleigh, North Carolina
Site status: Not listed — confirm with the team
SP Research PLLC
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Cutting Edge Research Group
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Carolina Clinical Trials, Inc.
Charleston, South Carolina
Site status: Not listed — confirm with the team
University of Texas at Austin
Austin, Texas
Site status: Not listed — confirm with the team
Community Clinical Research, Inc.
Austin, Texas
Site status: Not listed — confirm with the team
Pillar Clinical Research, LLC
Garland, Texas
Site status: Not listed — confirm with the team
Pillar Clinical Research, LLC
Richardson, Texas
Site status: Not listed — confirm with the team
Mid Columbia Research
Richland, Washington
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03259555. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Brexpiprazole, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: From 18 Years to 65 Years. The criteria appear strict, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.otsuka.co.jp/en/. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
